Multiple studies report that lower use of routine newborn vitamin K injections is associated with higher rates of infant bleeding, including more cases of intracranial hemorrhage. The reporting centers on large analyses of hospital births, which find that when fewer babies receive prophylactic vitamin K, bleeding risks increase.
MedPage Today and other outlets describe nationwide data involving more than 5 million infants, noting a sharp rise in bleeding outcomes among those who missed the shot. The New York Times and ABC News similarly frame the issue as a trend driven by more parents declining the injection, which is given at birth to help blood clot.
While the outlets agree on the direction of the relationship—declining vitamin K uptake correlates with increased bleeding—their emphasis differs. Some focus on the magnitude of the risk increase and specific outcomes like intracranial hemorrhage, while others foreground changing parental behavior and clinician experience.
